Sandy Spring Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $24.7K | Hold |
350
| – | – | ﹤0.01% | 696 |
|
|
2024
Q4 | $23K | Hold |
350
| – | – | ﹤0.01% | 723 |
|
|
2024
Q3 | $24.6K | Sell |
350
-50
| -13% | -$3.52K | ﹤0.01% | 721 |
|
|
2024
Q2 | $32.9K | Sell |
400
-50
| -11% | -$4.12K | ﹤0.01% | 665 |
|
|
2024
Q1 | $39.3K | Buy |
+450
| New | +$39.3K | ﹤0.01% | 629 |
|
|
2021
Q3 | – | Sell |
-15
| Closed | -$1K | – | 1138 |
|
|
2021
Q2 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 1102 |
|
|
2021
Q1 | – | Sell |
-14
| Closed | -$1K | – | 998 |
|
|
2020
Q4 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 918 |
|
|
2020
Q1 | – | Sell |
-139
| Closed | -$12K | – | 900 |
|
|
2019
Q4 | $12K | Buy |
+139
| New | +$12K | ﹤0.01% | 689 |
|
|
2019
Q3 | – | Sell |
-65
| Closed | -$6K | – | 842 |
|
|
2019
Q2 | $6K | Buy |
+65
| New | +$6K | ﹤0.01% | 757 |
|